Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$13.63 USD
-0.05 (-0.37%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $13.62 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RIGL 13.63 -0.05(-0.37%)
Will RIGL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RIGL
Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for RIGL
Rigel to Present at the 2024 Cantor Global Healthcare Conference
Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA? (olutasidenib) in mIDH1 AML
Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial
Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation
Rigel Expands Relationship with Kissei to include REZLIDHIA? (olutasidenib) in Japan, the Republic of Korea and Taiwan